Neo G Orthopedic Braces & Supports Australia

NEO G’s range of Medical Grade orthopaedic and sports supports were designed by highly qualified orthopaedic engineers and manufactured using cutting edge technology and medical grade materials.  Each product is rigorously tested to ensure it reaches Neo G’s exceptionally high standards. Be sure to check back regularly for an ever expanding range of Neo-G braces and supports in Australia (free shipping).

Neo G Orthopedic Braces & Supports Australia

The Neo-G AirFlow Breathable Armsling 997 has been designed to support and elevate the shoulder and arm in...
The Neo G Bunion Correction System Hallux Valgus Soft Support 510 has been designed to relieve the pain,...
The Neo G Airflow Wrist & Thumb Support 722 is the perfect solution for those who need support...
The Neo G Groin Support 888B has been specially designed to help support the adductor muscles and tendons...
The Neo G Calf/Shin Splint Support 892 helps support and protect the posterior and anterior muscles of the...
The Neo G Shoulder Support 896 is designed to relieve pain associated with shoulder injuries by providing compression,...
The Neo G Hinged Open Knee Support 894 offers a two point geared hinge system to help control...
$29.97
$64.97
$86.97
Showing: 1 -7 of 7
Spinner

Neo G Support, Compression & Braces Australia

Neo-G are a private limited company which was incorporated in the UK in July 2004. The firm employs more than 40 staff at its offices and warehouse in Harrogate. The group, founded by CEO Paul Starkey in 2004, has grown to be the UK’s leading brand of orthopaedic supports.

Neo G are medical product innovators of ‘Class 1 Medical Devices’, supplying medical professionals, therapists and sport markets worldwide with creative orthopaedic solutions. All products are manufactured in house at their own ISO, CE, MHRA (Medicines and Healthcare products Regulatory Agency, UK) and TGA (The Australian Therapeutic Goods Administration) registered factories in Europe. All their products offer cutting edge technology developed at their own in-house medical development facilities by fully qualified orthopaedic device designers.

The company already sells in 18 countries around the world, including Australia, and has ambitious growth plans for the US, where it aims to become the number one brand in the premium orthopaedic support market.

Neo G said their products use cutting edge materials and technology to provide relief from a number of conditions such as arthritis, carpal tunnel syndrome and back pain. Their range of patented arm, back and leg supports, plus compression hosiery, neck braces and products for hand rehabilitation and foot care, have been developed and tested in association with the UK’s Chartered Society of Physiotherapy.

Neo G’s product range underwent an independent review by a CSP nominated Chartered Physiotherapist and now bears the respected CSP logo, demonstrating the partnership to consumers and professionals alike. They operate in international markets including the USA, Australia, Europe and Canada as well as the UK.

Under the new partnership, Neo G has committed to continue to use the advice of Chartered Physiotherapists in developing its extensive ranges of premium orthopaedic supports, orthotics, insoles and hot & cold therapy products.

‘Neo-G will be well known to many CSP members.' says CSP director of strategy, policy and engagement Rob Yeldham. ”What members won’t have known is the commitment Neo G have to professional physiotherapy advice as part of their product development. This is the main reason we’ve chosen them as a partner.”

Managing Director and Founder, Paul Starkey has expressed delight in being able to work directly with and support the CSP, 'We are very proud to have achieved this latest accolade from the Chartered Society of Physiotherapy – physios are on the frontline, helping patients every day who manage a wide range of injuries and conditions. All of our products have been carefully developed and rigorously tested by orthopaedic professionals and we are confident they will be of significant benefit to CSP members and their patients.'